Why
SPRAVATO®
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).
No footer content content fetched
SPRAVATO®, the only FDA-approved nasal spray for adult patients with two forms of challenging-to-treat major depressive disorder (MDD):
- Adults with MDD who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD)
- Depressive symptoms in adults with MDD with suicidal thoughts or actions (MDSI)
See Limitations of Use below
Why
Getting Started
on SPRAVATO®
If you have treatment-resistant depression (TRD), you may benefit from adding SPRAVATO® to your current oral antidepressant.
Cost Support
& Education
Find a nearby SPRAVATO® treatment center and be prepared with our list of common insurance questions relating to SPRAVATO® coverage.
No footer links content fetched